ARK Investment Management - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 162 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$20,790,000
+70.6%
771,427
-52.9%
0.22%
-26.3%
Q1 2020$12,186,000
-19.5%
1,637,926
-64.3%
0.30%
-20.4%
Q4 2019$15,130,000
+74.8%
4,584,966
+8.6%
0.38%
+102.1%
Q3 2019$8,657,000
-25.6%
4,222,690
+6.8%
0.19%
-35.5%
Q2 2019$11,628,000
+6.4%
3,955,017
+35.0%
0.29%
-6.1%
Q1 2019$10,927,000
+44.9%
2,929,597
+55.4%
0.31%
+2.0%
Q4 2018$7,543,000
-29.2%
1,885,641
-1.6%
0.31%
-5.0%
Q3 2018$10,659,000
+127.6%
1,917,071
+60.5%
0.32%
+87.2%
Q2 2018$4,683,000
+49.7%
1,194,657
+79.8%
0.17%
+11.0%
Q1 2018$3,129,000
+164.7%
664,410
+132.1%
0.16%
+64.9%
Q4 2017$1,182,000
+128.6%
286,277
+334.4%
0.09%
-6.9%
Q2 2017$517,000
+112.8%
65,901
+79.2%
0.10%
+44.3%
Q1 2017$243,000
+12.0%
36,773
+17.8%
0.07%
-11.4%
Q4 2016$217,00031,2260.08%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 570,049$221,7490.17%
GMT CAPITAL CORP 1,513,500$588,7520.02%
Cedar Brook Financial Partners, LLC 130,522$50,7730.01%
Arlington Capital Management, Inc. 27,735$10,7890.01%
GSA CAPITAL PARTNERS LLP 296,948$1160.01%
Keystone Financial Group 109,897$42,7510.01%
Hennion & Walsh Asset Management, Inc. 163,562$63,6260.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,149,974$447,3400.00%
Freedom Investment Management, Inc. 62,298$24,2340.00%
Renaissance Technologies 4,889,500$1,9020.00%
View complete list of INOVIO PHARMACEUTICALS INC shareholders